why choose us

First received: March 01, 2023

Clinical Trial: Safety, Efficacy, & Use of Decellularized Femoral Artery Allograft (Nexeon AVX)

Study Status: Completed

Recruit Status: RECRUITING

Condition: End-Stage Renal Disease

Study Type: INTERVENTIONAL


Official Title: Safety, Efficacy, & Use of Decellularized Femoral Artery Allograft for Arteriovenous Access for Hemodialysis: A Multi-center Prospective Registry Study

Brief Summary: To assess the safety and efficacy of a novel decellularized human femoral artery allograft (Nexeon AVX Decellularized Femoral Artery,

Read more